Experiences of Respiratory Isolation and Costs for patients with TB
Research type
Research Study
Full title
Experiences of Respiratory Isolation and Costs for patients with Tuberculosis in the UK
IRAS ID
242060
Contact name
Danielle Cohen
Contact email
Sponsor organisation
Sheffield Teaching Hospitals NHS Foundation Trust
Duration of Study in the UK
1 years, 2 months, 2 days
Research summary
Tuberculosis (TB) is a major global public health problem. The disease is spread via the respiratory route and transmission in health care facilities is well-recognised. In order to prevent nosocomial spread, patients in the UK with TB admitted to hospital are cared for in single rooms, often for long periods. Recent NICE guidelines on TB management recognise that ‘isolation is known to significantly affect a person’s quality of life,’ but there are no reliable data on the impact of isolation on quality of life, or information to reflect the real costs of isolation. The aim of this study is to assess how respiratory isolation affects the experiences of patients being treated for TB. The outputs of the study will be used to develop better services for this complex group of patients in order to improve patient experience and clinical outcomes.
This exploratory study uses a mix of qualitative and quantitative methods to understand the experiences of patients with TB who undergo respiratory isolation. In-depth interviews will be conducted with patients to explore the physical, emotional, social and financial experiences associated with isolation. The financial consequences of illness will be investigated further using standardised questionnaires to estimate healthcare-associated user costs. The Hospital Anxiety and Depression Scale will be used to provide a quantitative measure of the psychological status of patients admitted to respiratory isolation.
REC name
London - Central Research Ethics Committee
REC reference
18/LO/1982
Date of REC Opinion
2 Nov 2018
REC opinion
Favourable Opinion